These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 33345970)
1. Cu Ramis R; Ortega-Castro J; Vilanova B; Adrover M; Frau J Int J Biol Macromol; 2021 Feb; 169():251-263. PubMed ID: 33345970 [TBL] [Abstract][Full Text] [Related]
2. Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure. Ponzini E; De Palma A; Cerboni L; Natalello A; Rossi R; Moons R; Konijnenberg A; Narkiewicz J; Legname G; Sobott F; Mauri P; Santambrogio C; Grandori R J Biol Chem; 2019 Apr; 294(14):5657-5665. PubMed ID: 30755483 [TBL] [Abstract][Full Text] [Related]
3. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease. Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094 [TBL] [Abstract][Full Text] [Related]
6. Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide. Kowalik-Jankowska T; Rajewska A; Jankowska E; Wiśniewska K; Grzonka Z J Inorg Biochem; 2006 Oct; 100(10):1623-31. PubMed ID: 16839607 [TBL] [Abstract][Full Text] [Related]
7. Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein. Rodríguez EE; Arcos-López T; Trujano-Ortiz LG; Fernández CO; González FJ; Vela A; Quintanar L J Biol Inorg Chem; 2016 Sep; 21(5-6):691-702. PubMed ID: 27422629 [TBL] [Abstract][Full Text] [Related]
8. Products of Cu(II)-catalyzed oxidation of alpha-synuclein fragments containing M1-D2 and H50 residues in the presence of hydrogen peroxide. Kowalik-Jankowska T; Rajewska A; Jankowska E; Grzonka Z Dalton Trans; 2008 Feb; (6):832-8. PubMed ID: 18239841 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders. Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160 [TBL] [Abstract][Full Text] [Related]
16. Epitope region identification challenges of intrinsically disordered proteins in neurodegenerative diseases: Secondary structure dependence of α-synuclein on simulation techniques and force field parameters. Mandaci SY; Caliskan M; Sariaslan MF; Uversky VN; Coskuner-Weber O Chem Biol Drug Des; 2020 Jul; 96(1):659-667. PubMed ID: 31903719 [TBL] [Abstract][Full Text] [Related]